TrianglePUBLICATIONS · 17132719
Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Blood
- Publication date
- 2007 Apr 1
- First author
- Patte C
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Patte C
- type
- Author
- name
- Auperin A
- type
- Author
- name
- Gerrard M
- type
- Author
- name
- Michon J
- type
- Author
- name
- Pinkerton R
- type
- Author
- name
- Sposto R
- type
- Author
- name
- Weston C
- type
- Author
- name
- Raphael M
- type
- Author
- name
- Perkins SL
- type
- Author
- name
- McCarthy K
- type
- Author
- name
- Cairo MS
- type
- Author
- name
- FAB/LMB96 International Study Committee
- type
- CollectiveName
Complete bibliographic record and source provenance
- authors
- name
- Patte C
- type
- Author
- name
- Auperin A
- type
- Author
- name
- Gerrard M
- type
- Author
- name
- Michon J
- type
- Author
- name
- Pinkerton R
- type
- Author
- name
- Sposto R
- type
- Author
- name
- Weston C
- type
- Author
- name
- Raphael M
- type
- Author
- name
- Perkins SL
- type
- Author
- name
- McCarthy K
- type
- Author
- name
- Cairo MS
- type
- Author
- name
- FAB/LMB96 International Study Committee
- type
- CollectiveName
- bibliography ids
- nci-bib-18a0a132f74174c79daf1b73
- book metadata
- content sha256
- 5daa7244c603822f29bb4fc4c9110af928299bb0f069bbfa4b3b57830f535a03
- document type
- citation
- dois
- 10.1182/blood-2006-07-036673
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:17132719
- immutable id
- pubmed:17132719@5daa7244c603822f29bb4fc4c9110af928299bb0f069bbfa4b3b57830f535a03
- journal
- abbreviation
- Blood
- issn electronic
- 1528-0020
- issn print
- 0006-4971
- issue
- 7
- name
- Blood
- nlm unique id
- 7603509
- pages
- 2773-80
- volume
- 109
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 17132719
- provenance
- batch id
- 2c499a3b9f4867a74c49
- provider
- NCBI PubMed ESummary
- record sha256
- 78db67986c01c583436ed886e3e5a58f7a6bfe382bbbb05b452f8696bb703b7d
- response sha256
- 3b299651c5c5270455877b65b6e5acff71ad5f85103b7f9582efe63c52588326
- retrieved at
- 2026-09-09T23:46:08.887541+00:00
- publication date
- display
- 2007 Apr 1
- precision
- day
- year
- 2007
- publication types
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients.
Preserved source evidence · Not medical advice